Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Fleisher

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Opinion in Allergy and Clinical Immunology|January 11, 2005
Autoimmune lymphoproliferative syndromeJoão B Oliveira, Thomas Fleisher
The Journal of Allergy and Clinical Immunology. in Practice|August 4, 2023
Preparing the Allergist/Immunologist for the Next PandemicPaul V Williams, Mary Beth Fasano, Thomas Fleisher
British Journal of Haematology|May 10, 2005
Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndromeV Koneti Rao, Faith Dugan, Janet K Dale, et al.
Arthritis and Rheumatism|January 30, 2010
Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation studyGabor G Illei, Yuko Shirota, Cheryl H Yarboro, et al.
Journal of Clinical Immunology|November 18, 2021
CARD9 Expression Pattern, Gene Dosage, and Immunodeficiency Phenotype RevisitedShubham Goel, Hye Sun Kuehn, Javier Chinen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2009
EBV-related lymphoproliferative disease complicating therapy with the anti-CD2 monoclonal antibody, siplizumab, in patients with T-cell malignanciesDeirdre O'Mahony, John C Morris, Maryalice Stetler-Stevenson, et al.
American Journal of Hematology|January 25, 2006
Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS)V Koneti Rao, Jorge A Carrasquillo, Janet K Dale, et al.
Pediatric Blood & Cancer|February 14, 2009
Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS)V Koneti Rao, Susan Price, Katie Perkins, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2008
Low- versus high-baseline epinephrine output shapes opposite innate cytokine profiles: presence of Lewis- and Fischer-like neurohormonal immune phenotypes in humans?Ilia J Elenkov, Richard Kvetnansky, Akira Hashiramoto, et al.
Human Mutation|July 24, 2010
A custom 148 gene-based resequencing chip and the SNP explorer software: new tools to study antibody deficiencyHong-Ying Wang, Vivek Gopalan, Ivona Aksentijevich, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Opinion in Allergy and Clinical Immunology|January 11, 2005
Autoimmune lymphoproliferative syndromeJoão B Oliveira, Thomas Fleisher
The Journal of Allergy and Clinical Immunology. in Practice|August 4, 2023
Preparing the Allergist/Immunologist for the Next PandemicPaul V Williams, Mary Beth Fasano, Thomas Fleisher
British Journal of Haematology|May 10, 2005
Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndromeV Koneti Rao, Faith Dugan, Janet K Dale, et al.
Arthritis and Rheumatism|January 30, 2010
Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation studyGabor G Illei, Yuko Shirota, Cheryl H Yarboro, et al.
Journal of Clinical Immunology|November 18, 2021
CARD9 Expression Pattern, Gene Dosage, and Immunodeficiency Phenotype RevisitedShubham Goel, Hye Sun Kuehn, Javier Chinen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2009
EBV-related lymphoproliferative disease complicating therapy with the anti-CD2 monoclonal antibody, siplizumab, in patients with T-cell malignanciesDeirdre O'Mahony, John C Morris, Maryalice Stetler-Stevenson, et al.
American Journal of Hematology|January 25, 2006
Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS)V Koneti Rao, Jorge A Carrasquillo, Janet K Dale, et al.
Pediatric Blood & Cancer|February 14, 2009
Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS)V Koneti Rao, Susan Price, Katie Perkins, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2008
Low- versus high-baseline epinephrine output shapes opposite innate cytokine profiles: presence of Lewis- and Fischer-like neurohormonal immune phenotypes in humans?Ilia J Elenkov, Richard Kvetnansky, Akira Hashiramoto, et al.
Human Mutation|July 24, 2010
A custom 148 gene-based resequencing chip and the SNP explorer software: new tools to study antibody deficiencyHong-Ying Wang, Vivek Gopalan, Ivona Aksentijevich, et al.
Pageof 2